Products are not medicines, are not intended for human consumption, and are not intended to diagnose, treat, cure or prevent any disease.
BPC157 5mg & 10mg
Price range: £17.95 through £27.95
BPC-157 peptide supplied in 5mg and 10mg options for controlled laboratory and in-vitro research. Each sealed vial contains lyophilised research material and is dispatched from the United Kingdom.
- Independent third-party batch testing
- ≥99% purity specification, subject to current batch documentation
- Current batch COA available on request
- Research use only
| Buy More, Pay Less | % Discount |
|---|---|
| 3 - 5 | 15% |
| 6 - 8 | 20% |
| 9 + | 25% |
BPC-157 Research Peptide
BPC-157 is a synthetic 15-amino-acid research peptide, also described as a pentadecapeptide, derived from a sequence associated with gastric peptide research.
Global Peptides supplies BPC-157 in 5mg and 10mg options as lyophilised research material for controlled laboratory and in-vitro applications only.
Product Specifications
| Compound | BPC-157 |
| Peptide type | Synthetic pentadecapeptide |
| Amino-acid length | 15 amino acids |
| Sequence | GEPPPGKPADDAGLV |
| Molecular formula | C62H98N16O22 |
| Molecular weight | Approximately 1419.5 g/mol |
| CAS number | 137525-51-0 |
| Form | Lyophilised powder |
| Available quantities | 5mg and 10mg |
| Purity specification | ≥99%, subject to current batch documentation |
| Testing | Independent third-party batch testing |
| Packaging | Sealed laboratory vial |
| Dispatch | United Kingdom |
| Intended use | Laboratory research only |
Research Context
BPC-157 is of interest in experimental research because of its peptide structure and its investigation across a range of cellular and biochemical models.
Preclinical laboratory research has examined BPC-157 in relation to cellular signalling, angiogenesis-related pathways, gastrointestinal research models, fibroblast activity, cellular migration and connective-tissue response mechanisms.
BPC-157 research remains predominantly experimental and preclinical. Findings from laboratory or animal models should not be interpreted as demonstrating an established effect in humans.
These research areas describe controlled laboratory investigation only and do not imply a clinical, medical, diagnostic or therapeutic application.
BPC-157 Peptide Structure
BPC-157 is a pentadecapeptide composed of 15 amino-acid residues. Its amino-acid sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
This corresponds to the abbreviated sequence GEPPPGKPADDAGLV.
The defined peptide sequence makes BPC-157 suitable for laboratory investigation involving peptide structure, molecular interactions and structure-activity relationships.
BPC-157 5mg and 10mg
Global Peptides currently supplies BPC-157 in 5mg and 10mg quantities.
Both options contain the same research compound in lyophilised form, with the selected quantity referring to the amount of BPC-157 supplied within the sealed laboratory vial.
The appropriate quantity depends on the requirements and design of the individual laboratory research protocol.
BPC-157 and Tissue-Response Research
A significant portion of published BPC-157 research involves experimental models examining tissue-response signalling and cellular processes.
Research areas may include cell migration, vascular signalling, fibroblast-related processes and experimental connective-tissue models.
These investigations are primarily preclinical. References to tissue-response research describe areas of scientific investigation and should not be interpreted as evidence of therapeutic efficacy or suitability for treating injuries or medical conditions.
BPC-157 and Gastrointestinal Research
BPC-157 has also been investigated extensively within experimental gastrointestinal research models.
The peptide is associated with research into gastric peptide biology and has been examined in laboratory and preclinical studies involving gastrointestinal tissues, cellular signalling and biological response pathways.
These research models do not establish BPC-157 as an approved treatment or medicine.
Independent Batch Testing
BPC-157 batches are submitted for independent analytical testing. Testing results apply specifically to the batch identified on the relevant Certificate of Analysis and should be read alongside the batch information supplied with the product.
Current batch COA available on request.
More information about our analytical testing and quality standards is available on our Quality & Testing page.
Storage and Laboratory Handling
Keep the sealed lyophilised vial in a cool, dry environment protected from heat, moisture and direct light. Handle only in appropriate laboratory conditions and follow suitable laboratory safety procedures.
Batch-specific documentation should take precedence where particular storage or handling requirements are provided.
Additional information is available in our peptide storage guide.
BPC-157 Frequently Asked Questions
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid research peptide. It is also described as a pentadecapeptide and is investigated in a range of experimental cellular, biochemical and tissue-response models.
What does BPC-157 stand for?
BPC-157 is commonly referred to as Body Protection Compound 157 in scientific and research literature.
How many amino acids are in BPC-157?
BPC-157 consists of 15 amino-acid residues, making it a pentadecapeptide.
What is the BPC-157 amino-acid sequence?
The BPC-157 sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, abbreviated as GEPPPGKPADDAGLV.
What is the molecular weight of BPC-157?
BPC-157 has a molecular weight of approximately 1419.5 g/mol.
What is the CAS number for BPC-157?
The CAS number commonly associated with BPC-157 is 137525-51-0.
What quantities of BPC-157 are available?
This product is currently available in 5mg and 10mg options. Select the required quantity using the product variation menu above.
How is BPC-157 supplied?
BPC-157 is supplied as lyophilised research material in a sealed laboratory vial.
What areas of research involve BPC-157?
Preclinical BPC-157 research has examined areas including cellular signalling, gastrointestinal models, angiogenesis-related pathways, cellular migration, fibroblast activity and tissue-response mechanisms.
Has BPC-157 been established as a human treatment?
No. BPC-157 remains an investigational research compound. Much of the published research is preclinical, and laboratory findings should not be interpreted as establishing safety or efficacy for human treatment.
Is independent testing documentation available?
Yes. Independent batch testing documentation is available on request for the applicable BPC-157 batch.
Where is BPC-157 dispatched from?
Orders are dispatched domestically from within the United Kingdom.
Is BPC-157 intended for human use?
No. BPC-157 supplied by Global Peptides is strictly for laboratory and in-vitro research. It is not supplied as a medicine and is not intended for human consumption, veterinary use, diagnosis or treatment.
| Quantity | 5mg, 10mg |
|---|